EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Radiogenomics: bridging the gap between imaging and genomics for precision oncology

Wenle He, Wenhui Huang, Lu Zhang, Xuewei Wu, Shuixing Zhang, Bin Zhang

MedComm · 2024-09 · 5 (9)

DOI: 10.1002/mco2.722 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 09.09.2024. Verfasst von Wenle He und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology The First Affiliated Hospital of Jinan University Guangzhou Guangdong China. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genomics allows the tracing of origin and evolution of cancer at molecular scale and underpin modern cancer diagnosis and treatment systems. Yet, molecular biomarker‐guided clinical decision‐making encounters major challenges in the realm of individualized medicine, consisting of the invasiveness of procedures and the sampling errors due to high tumor heterogeneity. By contrast, medical imaging enables noninvasive and global characterization of tumors at a low cost. In recent years, radiomics has overcomes the limitations of human visual evaluation by high‐throughput quantitative analysis, enabling the comprehensive utilization of the vast amount of information underlying radiological images. The cross‐scale integration of radiomics and genomics (hereafter radiogenomics) has the enormous potential to enhance cancer decoding and act as a catalyst for digital precision medicine. Herein, we provide a comprehensive overview of the current framework and potential clinical applications of radiogenomics in patient care. We also highlight recent research advances to illustrate how radiogenomics can address common clinical problems in solid tumors such as breast cancer, lung cancer, and glioma. Finally, we analyze existing literature to outline challenges and propose solutions, while also identifying future research pathways. We believe that the perspectives shared in this survey will provide a valuable guide for researchers in the realm of radiogenomics aiming to advance precision oncology.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligenceoncologyprecision medicineradiogenomicsradiomics

Autor:innen und Institutionen

  • Department of Radiology The First Affiliated Hospital of Jinan University Guangzhou Guangdong China.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

He, W., Huang, W., Zhang, L., Wu, X., Zhang, S., & Zhang, B. (2024). Radiogenomics: bridging the gap between imaging and genomics for precision oncology. MedComm, 5(9). https://doi.org/10.1002/mco2.722

Vancouver

He W, Huang W, Zhang L, Wu X, Zhang S, Zhang B. Radiogenomics: bridging the gap between imaging and genomics for precision oncology. MedComm. 2024;5(9). doi:10.1002/mco2.722

BibTeX
@article{He2024,
  author = {He, Wenle and Huang, Wenhui and Zhang, Lu and Wu, Xuewei and Zhang, Shuixing and Zhang, Bin},
  title = {Radiogenomics: bridging the gap between imaging and genomics for precision oncology},
  journal = {MedComm},
  year = {2024},
  volume = {5},
  number = {9},
  doi = {10.1002/mco2.722}
}
Kostenlos starten →